HONG KONG, Mar 25, 2022 – (ACN Newswire via SEAPRWire.com) – Angelalign Technology Inc. (“Angelalign” or “Company”; stock code 6699) was pleased to announce the …
Memiontec Secures its Largest Contract to date following Award of a New S$56.6 Million Contract by PUB
Singapore, Mar 25, 2022 – (ACN Newswire via SEAPRWire.com) – Memiontec Holdings Ltd. (“Memiontec” or the “Company”, and together with its subsidiaries, the “Group”), a …
IND Application for SinoMab’s First-in-Class Asthma Therapeutic Product SM17 Approved by FDA
HONG KONG, Mar 14, 2022 – (ACN Newswire via SEAPRWire.com) – SinoMab BioScience Limited (“SinoMab” or the “Company”, together with its subsidiaries, the “Group”, stock …
IND Application for SinoMab’s First-in-Class Asthma Therapeutic Product SM17 Accepted by FDA
HONG KONG, Feb 17, 2022 – (ACN Newswire via SEAPRWire.com) – SinoMab BioScience Limited (“SinoMab” or the “Company”, together with its subsidiaries, the “Group”, stock …
Biogen Announces Reduced Price for Aduhelm to Improve Access For Patients With Early Alzheimer’s Disease In The United States
TOKYO, Dec 21, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that, effective January 1, 2022, Biogen will reduce the wholesale …
Eisai Enters into Commercialization and Distribution Agreement with Gilead for JAK Inhibitor Filgotinib in Asia
TOKYO, Dec 20, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. today announced it has entered into an agreement with Gilead Sciences, Inc. …
Gradiant Secures Five New DBOOM Projects in Indonesia and Vietnam, Appoints Managing Directors to Fuel Growth
Singapore, Dec 2, 2021 – (ACN Newswire via SEAPRWire.com) – Gradiant, a leading global cleantech water treatment solutions provider and projects developer, has announced the …
Eisai Presents Late-Breaker Updates on Lecanemab Clinical, Biomarker and Safety Data from Phase 2b Study Core and Open-Label Extension
TOKYO, Nov 11, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. announced today results of new clinical, biomarker and safety …
Fujitsu and Aichi Cancer Center Develop AI System to Offer Patients Personalized Cancer Treatment
TOKYO, Oct 19, 2021 – (JCN Newswire via SEAPRWire.com) – Aichi Cancer Center (1) and Fujitsu Limited today announced the development of an AI solution …
Eisai Initiates Rolling Submission to the U.S. FDA for Biologics License Application of Lecanemab (BAN2401) for Early Alzheimer’s Disease Under the Accelerated Approval Pathway
TOKYO, Sep 28, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. today announced that Eisai has initiated a rolling submission …
Gradiant Achieves Strong Growth Across Asia in Cleantech Water Treatment during the Pandemic
– Gradiant demonstrated strong growth during the prolonged COVID-19 pandemic– Gradiant won 26 new projects in 2021 YTD across the Asia Pacific region– Contract wins …
New treatment option for schizophrenia Reagila(R) listed on PBS
MELBOURNE, Sep 6, 2021 – (ACN Newswire via SEAPRWire.com) – A new treatment for schizophrenia in adults, Reagila(R) (cariprazine), was listed on the Pharmaceutical Benefits …
Eisai and Biogen Present Preliminary Assessment of the Clinical Effects of Lecanemab (BAN2401)
TOKYO, Jul 30, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. today announced results of a longitudinal preliminary assessment of …
Biogen and Eisai Announce ADUHELMTM (aducanumab-avwa) Data Presentations at Alzheimer’s Association International Conference 2021
TOKYO, Jul 27, 2021 – (JCN Newswire via SEAPRWire.com) – Biogen (Nasdaq: BIIB) and Eisai Co., Ltd. (Tokyo, Japan) today announced that Biogen, as part …
Central Global Bhd Signs MoU for JV to Build RM250M Kwasa Damansara Sewage Treatment Plant
KUALA LUMPUR, Jun 9, 2021 – (ACN Newswire via SEAPRWire.com) – Main Market-listed Central Global Berhad’s (“CGB) construction arm, Proventus Bina Sdn Bhd (“PBSB”), has …
MHIEC Supplies Incinerators for First Waste-to-Energy Plant in Xiaogan, Hubei Province, China
TOKYO, Apr 27, 2021 – (JCN Newswire via SEAPRWire.com) – Mitsubishi Heavy Industries Environmental & Chemical Engineering Co., Ltd. (MHIEC), a part of Mitsubishi Heavy …
Hua Medicine Announces Acceptance of a New Drug Application for Dorzagliatin in China – First Glucokinase Activator (GKA) Globally
SHANGHAI, CHINA, Apr 23, 2021 – (ACN Newswire via SEAPRWire.com) – Hua Medicine (the “Company”, Stock Code: 2552.HK), today announced that the New Drug Application …
Insurance: Pay more if you see your own doctors
Unless you are prepared to pay more, the days of consulting private doctors who are not on your insurers’ panels for hospital treatment will soon …
Suntrap Life Technologies Discovers Natural anti-COVID-19 Compound
Guangzhou, China, Dec 23, 2020 – (ACN Newswire) – ‘LeSoleil’, a naturally active compound, was discovered as a therapeutic candidate for use against COVID-19. As …